Merck Co MRK Receives FDA Priority Review for KEYTRUDA Combination Regimens in MuscleInvasive Bladder Cancer NODK NI Holdings posts Q4 2022 EPS of 004 shares drop 061 after earnings announcement Lucid Group LCID Material Fundamental Red Flags Amid Broader Industrial Sector Rally XMTR Xometry posts 423 percent Q4 2025 EPS beat pushing shares up 177 percent in daily trading Dolphin Ent DLPN Stock Watch Key Levels Steady Decline 20260420